Newman Dignan & Sheerar, Inc. Amgen Inc Transaction History

Newman Dignan & Sheerar, Inc.

$585 Million
Q3 2024

A detailed history of Newman Dignan & Sheerar, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 8,163 shares of AMGN stock, worth $2.16 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

8,163

Previous 8,193 0.37%

Holding current value

$2.16 Million

Previous $2.56 Million 2.77%

% of portfolio

0.45%

Previous 0.66%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $9,281 - $10,121	-30 Reduced 0.37%	8,163 $2.63 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $181,034 - $220,004	-689 Reduced 7.76%	8,193 $2.56 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $137,930 - $166,499	-513 Reduced 5.46%	8,882 $2.53 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $20,200 - $22,788	-79 Reduced 0.83%	9,395 $2.71 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $58,379 - $72,479	-267 Reduced 2.74%	9,474 $2.55 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $12,213 - $14,442	-57 Reduced 0.58%	9,741 $2.16 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $34,094 - $41,555	-151 Reduced 1.52%	9,798 $2.37 Million
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $458 - $582	2 Added 0.02%	9,949 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $7,856 - $8,860	-35 Reduced 0.35%	9,947 $2.24 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $15,918 - $17,715	69 Added 0.7%	9,982 $2.43 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $2,631 - $2,910	12 Added 0.12%	9,913 $2.4 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $13,126 - $15,021	-66 Reduced 0.66%	9,901 $2.23 Million
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.01%	9,967 $2.12 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $27,796 - $30,837	-119 Reduced 1.18%	9,966 $2.43 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $118,721 - $138,351	-535 Reduced 5.04%	10,085 $2.51 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $21,205 - $25,251	-98 Reduced 0.91%	10,620 $2.44 Million
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $4,458 - $4,958	-19 Reduced 0.18%	10,718 $2.72 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $26,704 - $32,769	135 Added 1.27%	10,737 $2.64 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $19,681 - $26,103	-108 Reduced 1.01%	10,602 $2.35 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $16,272 - $20,915	-86 Reduced 0.8%	10,710 $2.58 Million
Q3 2019 Oct 21, 2019	BUY	$174.11 - $208.62 $13,928 - $16,689	80 Added 0.75%	10,796 $2.09 Million
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $44,175 - $51,783	-265 Reduced 2.41%	10,716 $1.98 Million
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $44,674 - $50,358	-247 Reduced 2.2%	10,981 $2.09 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $90,984 - $106,207	510 Added 4.76%	11,228 $2.19 Million
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $25,199 - $28,409	136 Added 1.29%	10,718 $2.19 Million
Q2 2018 Jul 06, 2018	BUY	$166.05 - $186.51 $35,202 - $39,540	212 Added 2.04%	10,582 $1.95 Million
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $101,827 - $118,998	-601 Reduced 5.48%	10,370 $1.78 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $19,410 - $21,687	-115 Reduced 1.04%	10,971 $1.91 Million
Q3 2017 Oct 18, 2017	SELL	$167.29 - $191.0 $24,926 - $28,459	-149 Reduced 1.33%	11,086 $2.07 Million
Q2 2017 Aug 08, 2017	BUY	N/A	11,235	11,235 $1.94 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Account

Newman Dignan & Sheerar, Inc. Amgen Inc Transaction History